Patents for A61P 27 - Drugs for disorders of the senses (53,017)
06/2003
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045930A1 Therapeutic compounds
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045917A2 Ccr-3 receptor antagonists vii
06/05/2003WO2003045902A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045432A1 Treatment of neovascular ophthalmic disease
06/05/2003WO2003045417A1 Antiglaucomatous agent and use thereof
06/05/2003WO2003045393A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003WO2003045384A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045368A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003WO2003045367A1 Angiogenesis inhibitor
06/05/2003WO2003045338A1 Compositions comprising phenyl-glycine derivatives
06/05/2003WO2003045333A2 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2002060864A9 Process of obtaining compositions of stable lutein and lutein derivatives
06/05/2003US20030106082 Transgenic stem cells, formed by dissociating blastomeres, are cultured, impregnated within surrogate; animals models; gene therapy
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105167 Using polycyclic phenolic compound
06/05/2003US20030105155 Prostanoic acid derivatives as agents for lowering intraocular pressure
06/05/2003US20030105150 Method of treating of demyelinating diseases or conditions
06/05/2003US20030105147 Analgesics, sedatives, anesthetics
06/05/2003US20030105135 Adrenergic receptors; gastrointestinal disorders, dietetics, urogenital disorders, antidiabetic agents
06/05/2003US20030105123 For therapy of respiratory system disorders
06/05/2003US20030105107 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/05/2003US20030105089 Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease
06/05/2003US20030105088 Thiol-based NAALADase inhibitors
06/05/2003US20030104992 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
06/05/2003US20030104977 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
06/05/2003US20030104975 Useful for identification of compounds that induce or inhibit the recruitment of the p160 family cofactors, especially TIF-2 and/ or SRCs cofactors (Translation initiation factor-2 and steroid receptor cofactors)
06/05/2003US20030104532 Neuroprotectants; angoigenesis inhibitors; transcription factors
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
06/05/2003US20030103973 Method for reducing tumor growth with VEGF antagonists combined with radiation and chemotherapy
06/05/2003CA2468402A1 Ccr-3 receptor antagonists vii
06/05/2003CA2468280A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003CA2468256A1 Compositions comprising phenyl-glycine derivatives
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468071A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003CA2467966A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2466867A1 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003CA2466864A1 Treatment of neovascular ophthalmic disease
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/04/2003EP1316559A1 Adenosine derivatives and use thereof
06/04/2003EP1316547A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)- n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient
06/04/2003EP1316310A1 Ophthalmic composition comprising a histidine derivative for healing asthenopia
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315741A2 A method for treating allergies
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315731A1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
06/04/2003EP1315730A1 1-(alkyl), 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo(1,2-a)pyrimidin-5(1h)-one derivatives
06/04/2003EP1315727A2 7-oxo pyridopyrimidines
06/04/2003EP1315705A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315700A2 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
06/04/2003EP1315502A1 Method for treating erectile dysfunction and increasing libido in men
06/04/2003EP1315501A1 Alpha v integrin receptor antagonists
06/04/2003EP1216046B1 Novel combination of loteprednol and antihistamines
06/04/2003EP1075476B1 Novel benzimidazoles and benzoxazoles
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0927031B1 Pharmaceutical preparation containing nimesulide for oral administration
06/04/2003EP0901487B1 2,3,6 trisubstituted-4(3h)-quinazolinones
06/04/2003EP0863875B1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003EP0689438B1 Pharmaceutical compositions for intranasal administration of apomorphine
06/04/2003EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
06/04/2003EP0606366B1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use
06/04/2003CN1422270A Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422257A Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
06/04/2003CN1422254A Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
06/04/2003CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands
06/04/2003CN1422157A Divided dose therapies with vascular damaging activity
06/04/2003CN1422148A Method for treating dry eye
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/03/2003US6573390 Muscle relaxant, hypotensive agent, respiratory system disorders, gastrointestinal disorders, fertility, incontinence, shock, antiinflammatory agents, immunology, bone disorders, antiproliferative agents
06/03/2003US6573376 Solvent extraction; plant extracts
06/03/2003US6573294 Method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound
06/03/2003US6573280 Glutamate causes migration and proliferation of retinal pigment epithelium and/or glial cells, and glutamate antagonists can prevent, treat or reduce retinal pigment epithelium and/or glial migration and the subsequent
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573273 Urea substituted imidazoquinolines
06/03/2003US6573271 Following surgery or trauma or resulting in ocular diseases associated with choroidal neovascularization, such as age related macular degeneration and histoplasmosis syndrome
06/03/2003US6573270 Endothelin receptor antagonists
06/03/2003US6573066 FtsH from Staphylococcus aureus
06/03/2003US6572861 Lecithin, oil in water emulsion and an amphiphilic surfactant; minimize local reactions to the vaccine
06/03/2003US6572858 Uses for anti-malarial therapeutic agents
06/03/2003US6572841 Composition and method for decreasing upper respiratory airway resistance
06/03/2003CA2282757C Opthalmic composition
06/03/2003CA2047858C (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
05/2003
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
05/30/2003WO2003044009A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003044000A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043999A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043986A1 Polypeptides of moraxella (branhamella) catarrhalis